Rick Pauls
Chief Executive Officer at DIAMEDICA THERAPEUTICS INC.
Net worth: 392 756 $ as of 2024-05-30
Network origin in Rick Pauls first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 36 | |
CentreStone Ventures, Inc.
 CentreStone Ventures, Inc. Investment ManagersFinance CentreStone Ventures Inc (CentreStone) is an independent venture capital firm founded in 2004. The firm is headquartered in Winnipeg, Manitoba.
2
| Private Company | Investment Managers | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Rick Pauls via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| MEDICURE INC. | Pharmaceuticals: Major | Director of Finance/CFO Chief Executive Officer Chief Tech/Sci/R&D Officer Director of Finance/CFO Director of Finance/CFO Director of Finance/CFO | |
| University of Manitoba | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree Doctorate Degree Masters Business Admin | |
| KANE BIOTECH INC. | Miscellaneous Commercial Services | Director/Board Member Chairman Director of Finance/CFO Director of Finance/CFO | |
University of Minnesota
 University of Minnesota Other Consumer ServicesConsumer Services Digi-Key Corp. distributes electronic components. It also distributes semiconductors, discrete, electromechanical parts. Its products include audio products, batteries, cable assemblies, capacitors, computer & video accessories, connectors, crystals & oscillators, discrete semiconductor products and many more. The company was founded by Ronald A. Stordahl in 1972 and is headquartered in Thief River Falls, MN. | College/University | Corporate Officer/Principal Doctorate Degree Undergraduate Degree | |
| EDGEWISE THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| TRILLIUM THERAPEUTICS | Biotechnology | Chief Executive Officer Director of Finance/CFO | |
| Life Sciences Ontario | Director/Board Member Director/Board Member | ||
| Genesys Pharma, Inc. | Founder Public Communications Contact | ||
Genesys Venture, Inc.
 Genesys Venture, Inc. Financial ConglomeratesFinance Genesys Venture, Inc. operates as an investment firm, which specializes in health and biotechnology ventures. It offers life science accelerator services such as start-up, early-mid stage capitalization, business development, technology development, intellectual property management, and accounting and finance. The company was founded by Albert D. Friesen and Dawson J. Reimer in 1997 and is headquartered in Winnipeg, Canada. | Financial Conglomerates | Founder Founder | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| The University of Waterloo | College/University | Graduate Degree Graduate Degree | |
Eluminex Biosciences Ltd.
 Eluminex Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Eluminex Biosciences Ltd. is a Chinese clinical-stage biotechnology company that focuses on the development and commercialization of innovative therapeutics for ophthalmic diseases. Eluminex's headquarters and research and development center are located in Biobay Industrial Park, with a US-subsidiary located in the area. The private company has developed a pipeline of next-generation protein therapeutics for retinal diseases, including age-related macular degeneration, macular edema, and diabetic retinopathy. The company is devoted to innovating the next generation of first-in-class or ocular therapeutics for vision-threatening or lifestyle-limiting ocular diseases. Eluminex has exclusively licensed rights for the development and commercialization of an investigational clinical-stage biosynthetic cornea derived from recombinant human collagen type III for the treatment of corneal blindness. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal President | |
Elan Pharmaceuticals, LLC
 Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| WAVERLEY PHARMA INC. | Pharmaceuticals: Major | Director of Finance/CFO Chairman | |
| Stanford University | College/University | Corporate Officer/Principal | |
| Max-Planck-Institute for Molecular Genetics | College/University | Corporate Officer/Principal | |
Lilly Deutschland GmbH
 Lilly Deutschland GmbH Pharmaceuticals: MajorHealth Technology Part of Eli Lilly & Co., Lilly Deutschland GmbH is a pharmaceutical company based in Bad Homburg, Germany. The German company manufactures pharmaceutical products. The company was founded in 1960 by Eli Lilly. The CEO is Kadir Tepebasi. | Pharmaceuticals: Major | President | |
| The University of North Carolina at Asheville | College/University | Doctorate Degree | |
| Bristol-Myers Squibb Pharmaceutical Research Institute | Corporate Officer/Principal | ||
| Vanderbilt University | College/University | Corporate Officer/Principal | |
| Vanderbilt University School of Medicine | College/University | Corporate Officer/Principal | |
| Intuitive Quantitation LLC | Corporate Officer/Principal | ||
| Smart Bioscience SAS | Chief Tech/Sci/R&D Officer | ||
| Central College | College/University | Undergraduate Degree | |
American College of Cardiology Foundation
 American College of Cardiology Foundation Medical/Nursing ServicesHealth Services American College of Cardiology Foundation provides cardiovascular education services. Its services include cardiac surgery, chronic angine, diabetes, geriatric cardiology and heart failure and cardiomyopathies. The company was founded by Franz Groedel, Robert P. Glover and Bruno Kisc in 1949 and is headquartered in Washington, DC. | Medical/Nursing Services | Corporate Officer/Principal | |
| Brighton Asset Management LLC | Chief Executive Officer | ||
SARcode Bioscience, Inc.
 SARcode Bioscience, Inc. Pharmaceuticals: MajorHealth Technology SARcode Bioscience, Inc., develops biopharmaceutical products. Its program is a novel class of lymphocyte function-associated antigen-1 (LFA-1) antagonists for the treatment T-cell mediated inflammatory diseases. The company was founded by Thomas Gadek and John P. Burnier in 2006 and is headquartered in Brisbane, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Carleton College | College/University | Undergraduate Degree | |
The American College of Radiology
 The American College of Radiology Miscellaneous Commercial ServicesCommercial Services The American College of Radiology is a national organization serving radiologists, radiation oncologists, interventional radiologists, and medical physicists with programs focusing on the practice of radiology and the delivery of comprehensive health care services. ACR devotes its programs to make imaging safe, effective, and accessible. The college publishes the journal of the American College of Radiology and the ACR bulletin. It also provides the national accreditation program for mammography. ACR also hosts the ACR career center for radiologists. The College was founded in 1923 and its office is located in Reston, VA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
WR Midco Ltd.
 WR Midco Ltd. Medical/Nursing ServicesHealth Services Part of Welltower, Inc., WR Midco Ltd. is a holding British company that operates subsidiaries providing senior residential assisted living facilities. The company is based in London, UK. Founded in 2016, WR Midco focuses on offering high-quality care and support for seniors in a comfortable and safe environment. | Medical/Nursing Services | Director/Board Member | |
| ANDLAUER HEALTHCARE GROUP INC. | Air Freight/Couriers | Director/Board Member | |
Lumanity, Inc.
 Lumanity, Inc. Miscellaneous Commercial ServicesCommercial Services Lumanity, Inc. is a British company that specializes in transforming data into real-world insights and evidence to power successful commercialization and empower stakeholders to take timely and decisive action. The company is based in London, UK. and has subsidiaries in United States and United Kingdom. Jon Williams has been the CEO of the company since 2022. | Miscellaneous Commercial Services | Director/Board Member | |
| COTINGA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member | |
| Queen's University | College/University | Undergraduate Degree | |
Atlantic Healthcare Plc
 Atlantic Healthcare Plc Pharmaceuticals: MajorHealth Technology Atlantic Healthcare Plc operates as holding company with interest in pharmaceutical. Its products include Alicaforsen Enema, an anti-inflammatory intercellular adhesion molecule inhibitor that acts by inhibiting a key protein in the inflammation process. The firm offers its product for the treatment of pouchitis and ulcerative colitis. The company was founded by Toby Wilson Waterworth and Fiona Mary Wilson Waterworth in 2006 and is headquartered in Saffron Walden, the United Kingdom. | Pharmaceuticals: Major | Chairman | |
2ndsite, Inc.
 2ndsite, Inc. Packaged SoftwareTechnology Services 2ndsite, Inc. operates cloud-based accounting software. The firm's products include invoice, expenses and receipts, managing products, time tracking, online payments, financial reports, mobile apps, pricing, and high volume billing. The company was founded by Mike McDerment, Joe Sawada and Levi Cooperman in January 2003 and is headquartered in Toronto, Canada. | Packaged Software | Director/Board Member | |
Therapure Biopharma, Inc.
 Therapure Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Therapure Biopharma, Inc. engages in the business of contract development and manufacturing. It operates through the following divisions: Therapure Biomanufacturing, Therapure Innovations, and Evolve Biologics. The Therapure Biomanufacturing division focuses on contract development and manufacturing of complex biologics. The Therapure Innovations division includes in-house proprietary-drug development. The Evolve Biologics division develops a portfolio of plasma-derived pharmaceutical products. The company was founded on June 22, 2007 and is headquartered in Mississauga, Canada. | Pharmaceuticals: Major | Chief Executive Officer | |
Lumanity, Inc. (United States)
 Lumanity, Inc. (United States) Data Processing ServicesTechnology Services Part of Lumanity, Inc., the company is a data analytics firm based in Bethesda, MD. The company specializes in transforming data into real-world insights and evidence to power successful commercialization and empower stakeholders to take timely and decisive action. Jon Williams has been the CEO of the company since 2022. | Data Processing Services | Director/Board Member | |
| CIPHER PHARMACEUTICALS INC. | Pharmaceuticals: Other | Director/Board Member | |
| RDP Consulting, Inc. | Director/Board Member | ||
| WCG CLINICAL, INC. | Biotechnology | Director/Board Member |
Statistics
International
| United States | 26 |
| Canada | 18 |
| United Kingdom | 5 |
| Germany | 3 |
| China | 2 |
Sectoral
| Health Technology | 19 |
| Consumer Services | 12 |
| Commercial Services | 5 |
| Finance | 4 |
| Health Services | 4 |
Operational
| Director/Board Member | 116 |
| Corporate Officer/Principal | 59 |
| Director of Finance/CFO | 41 |
| Chief Tech/Sci/R&D Officer | 37 |
| President | 29 |
Most connected contacts
| Insiders | |
|---|---|
| Thomas Wellner | 31 |
| Pieter de Visser | 26 |
| Albert Friesen | 25 |
| Richard Kuntz | 23 |
| Richard Pilnik | 20 |
| Michael Giuffre | 18 |
| David Allan | 16 |
| Charles Semba | 13 |
| Amy Burroughs | 12 |
| Lorianne K. Masuoka | 12 |
| Todd A. Verdoorn | 12 |
| Harry W. Alcorn | 12 |
| Tanya Lewis | 11 |
| James Parsons | 10 |
| Mark Williams | 9 |
- Stock Market
- Insiders
- Rick Pauls
- Company connections
